Canada markets close in 1 hour 1 minute

Iterum Therapeutics plc (ITRM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1000+0.0200 (+1.85%)
As of 02:42PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 14.07M
Enterprise Value -20.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.43
Enterprise Value/Revenue 105.22
Enterprise Value/EBITDA 0.55

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-82.44%
S&P500 52-Week Change 3-12.21%
52 Week High 37.0500
52 Week Low 30.6010
50-Day Moving Average 31.1934
200-Day Moving Average 32.0645

Share Statistics

Avg Vol (3 month) 3100.63k
Avg Vol (10 day) 3103.28k
Shares Outstanding 512.6M
Implied Shares Outstanding 6N/A
Float 811.85M
% Held by Insiders 11.03%
% Held by Institutions 12.48%
Shares Short (Feb 27, 2023) 4182.69k
Short Ratio (Feb 27, 2023) 42.44
Short % of Float (Feb 27, 2023) 41.51%
Short % of Shares Outstanding (Feb 27, 2023) 41.49%
Shares Short (prior month Jan 30, 2023) 4312.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Aug 17, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.98%
Return on Equity (ttm)-113.59%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.58M
Net Income Avi to Common (ttm)-44.43M
Diluted EPS (ttm)-3.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)60.8M
Total Cash Per Share (mrq)4.95
Total Debt (mrq)28.47M
Total Debt/Equity (mrq)101.67
Current Ratio (mrq)6.89
Book Value Per Share (mrq)2.28

Cash Flow Statement

Operating Cash Flow (ttm)-18.47M
Levered Free Cash Flow (ttm)-17.93M